Name: Funding in the Golden Age of Biotech
Start: 2019-04-12T15:30:00-0400
End: 2019-04-12T16:15:00-0400

THE BIG FESTIVAL ABOUT SMALL CITIES
Tom Tom champions civic innovation, creativity, and entrepreneurship in America’s hometowns.

[Back to Tom Tom Festival]

Back To Schedule

Funding in the Golden Age of Biotech

Feedback form is now closed.

Biotech industry experienced a record-breaking year in 2018 with 60 IPOs and and significant private capital investment in startups. What is causing VCs to be so bullish on biotech and what does it take to adequately fund a biotech venture? Hear insights from the source of 2 VCs paying close attention to the biotech space in this enlightening conversation and audience Q+A.

You need this ticket from Eventbrite to sign up: Entrepreneurial Ecosystems Conference.

Moderators

Carleen Bowers

Venture Associate, UVA LVG Seed Fund

Carleen joined the University of Virginia’s Seed Fund in 2018 as a Venture Associate, and is responsible for identifying and evaluating early stage venture investment opportunities emerging from the University. She also works to support the growth of the Fund’s five portfolio... Read More →

Speakers

Jill Carroll

Principal, SR One

Jill joined SR One in 2011 with a background in biotech partnering and corporate development. Previously, she completed multiple pharma partnerships and substantial private and public financings at Dynavax Technologies (NASDAQ: DVAX). Jill was formerly a biopharmaceutical industry... Read More →

Jason Fuller

Principal, New Enterprise Associates

Jason joined NEA as a Principal in 2014 and focuses on investments in biopharmaceuticals. Prior to joining NEA, Jason was a Principal with Third Rock Ventures were he contributed to the creation and management of several companies, including NinePoint Medical, Kala Pharmaceuticals... Read More →

Sponsors